Fact CheckerSign in

NCT06697561Active, not recruiting

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma: A Randomized Control Trail

Source: ClinicalTrials.gov · Last updated 20 Nov 2024

Brief summary (registry, in English)

The purpose of this study is to develop an evidence-based educational program for scleroderma patients with hand dysfunction. The program includes a self-care handbook and multimedia video resources. The study aims to answer: Does the intervention improve hand function in the experimental group compared to the control group? Does the intervention improve self-care knowledge of hand dysfunction? Does the intervention improve overall health? Participants will receive an 8-week program, while the control group receives usual care. Outcome measures include hand function, overall health, and self-care knowledge.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
16 Nov 2024
Start date
30 Jul 2024
Primary completion date
30 Jun 2025
Lead sponsor
Wen-Shao Lin
NCT number
NCT06697561

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 30 Jul 2024 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 2, Participants with organic brain dysfunction. 3. Participants with severe visual or hearing impairments. 4. Participants with serious illnesses that hinder communication or interfere with the normal learning process.

Other

  • 1\. Participants who have participated in any other hand rehabilitation program within the past three months.

Who the study is looking for

  • Participants with systemic sclerosis who meet the 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) diagnostic criteria and have hand dysfunction.
  • Adults aged 18 years or older.
  • Participants who are conscious and able to communicate in Mandarin Chinese or Taiwanese Hokkien.
  • Participants who provide informed consent to participate in the study after being briefed on its purpose.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cheng Hsin General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.